Skip to content
NAICS 2022 325414 32541 ↗
● Official Registry Data: 2026-11-19

325414 — Biological Product (except Diagnostic) Manufacturing

NAICS 2022 325414 (Biological Product (except Diagnostic) Manufacturing) classifies within economic division 21 (Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization), linking EU/UN activity boundaries with US NAICS, UK SIC, and national regulatory obligations.

01 / Standard & Revision
NAICS 2022

U.S. Census Bureau • v2022

02 / Parent Hierarchy
32541

Pharmaceutical and Medicine Manufacturing

03 / Mapped Standards
5

ISIC 2100

04 / Subclasses & Scope
1 Items

MCC 5122

01 / OFFICIAL SCOPE & OPERATORS

Activity Scope, Operators & Exclusions

Who Uses This Code & Typical Business Models

  • Active pharmaceutical ingredient (API) and finished drug makers
  • Vaccine, biologic, serum, and diagnostic preparation labs
  • Veterinary medicine and medicated surgical dressing manufacturers

This Class Includes

1
  • This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

This Class Excludes (Cross-References)

0

—

02 / REGULATORY & TAX DOSSIER

Legislation, Licensing, Incorporation & Tax Framework

Div. 21 • Sec. C Law 6948 Industrial Reg.

Governing Statutes & Regulations

Pharmaceutical Preparations Law No. 1262 EU-harmonized Pharmaceutical GMP Regulation Drug Marketing Authorization Reg. Industrial Registry Law No. 6948

Mandatory Permits, Licenses & Authorities

  • TİTCK Manufacturing Authorization, Good Manufacturing Practice (GMP) Certificate, and Drug Marketing Authorizations
  • İTS serialization integration & mandatory Qualified Person (Mesul Müdür)
  • Ministry of Agriculture Veterinary Drug License for 21.20 animal formulations

Incorporation Route & Chamber Registration

EU NACE Rev. 2.1 Framework
Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.
United States (IRS / SBA / NAICS)
Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization.
United Kingdom (Companies House / HMRC)
Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.

VAT, Withholding & Statutory Incentives

  • Licensed pharmaceuticals carry 10% reduced VAT in Turkey.
  • Classified as High-Technology Manufacturing: qualifies for KOSGEB Business Dev grants, Law 5746 R&D Center deductions, and Priority/Strategic Investment Incentives.

Cross-Border Regulatory Frameworks (EU / US / UK)

TR • Corporate & Tradesmen Registry

Chamber of Industry / Commerce + Industrial Registry (Capital Company required) — JSC/LLC structure mandatory for GMP pharmaceutical manufacturing.

EU / Global Technical Alignment

Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.

AUDIT & BOUNDARY CHECK

Classification Boundaries & Audit Risks

  • Dietary supplements and vitamins belong in Div. 10 (10.89) under Food Law, not Div. 21 drugs.
  • Non-medicated medical devices and surgical instruments sit in Div. 32 (32.50).
04 / INTERNATIONAL CROSSWALK & MCC

Global Classification Passport

Verified structural and concordance mappings across EU, US, UK, UN, and national registries.

Payment Processing & ISO 18245 MCC Profile

Visa / Mastercard ISO 18245
MCC 5122
High Risk / Reserve Review
Drugs, Drug Proprietaries and Druggists Sundries

Strictly underwritten: non-OTC pharmaceuticals require pharmacy licensing and Card Brand high-risk registration.

05 / BOUNDARIES & COMPARISON

Critical Distinctions & Sibling Codes

Open Full Comparison Tool →
06 / TAXONOMY TREE

Classification Hierarchy & Data Export

07 / FAQ

Frequently Asked Questions

What business activities and models fall under NAICS 2022 325414?

325414 (Biological Product (except Diagnostic) Manufacturing): This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).. Typical operators: Active pharmaceutical ingredient (API) and finished drug makers; Vaccine, biologic, serum, and diagnostic preparation labs.

What regulatory licensing and tax rules apply to 325414 across EU, US, UK, or Turkey?

EU: Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization. US: Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization. UK: Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.

What are the international classification equivalents and MCC code for 325414?

Verified concordance for 325414: UN ISIC Rev. 5: 2100 • Payment MCC 5122 (Drugs, Drug Proprietaries and Druggists Sundries).